アブストラクト
| Title | [合併症の予防と治療] 敗血症性DIC |
|---|---|
| Subtitle | 特集 エキスパートが直伝! 敗血症の薬学的管理 最新版 |
| Authors | 工藤大介, 久志本成樹 |
| Authors (kana) | |
| Organization | 東北大学大学院医学系研究科外科病態学講座救急医学分野 |
| Journal | 月刊薬事 |
| Volume | 63 |
| Number | 9 |
| Page | 1795-1800 |
| Year/Month | 2021 / 7 |
| Article | 報告 |
| Publisher | じほう |
| Abstract | [Points] ●敗血症における生体防御機構を逸脱した凝固線溶反応が播種性血管内凝固症候群(DIC)である. ●わが国で広く用いられている敗血症性DICの診断基準は, 日本救急医学会の急性期DIC診断基準である. ●敗血症にDICを合併した患者は, 非合併患者と比較して死亡率が高い. ●敗血症性DICに対する治療は, 抗凝固療法である. ●各々の抗凝固薬の特徴とリスクを理解して使用するべきである. |
| Practice | 薬学 |
| Keywords |
- 全文ダウンロード： 従量制、基本料金制の方共に803円(税込) です。
参考文献
- 1) Engelmann B, et al : Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol, 13 : 34-45, 2013
- 2) Singer M, et al : The third international consensus definitions for sepsis and septic shock(Sepsis-3). JAMA, 315 : 801-810, 2016
- 3) 丸藤 哲, 他 : 急性期DIC基準 多施設共同前向き試験結果報告. 日本救急医学会雑誌, 16 : 188-202, 2005
- 4) Taylor FB Jr, et al : Towards definition, clinical and labo-ratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost, 86 : 1327-1330, 2001
- 5) Iba T, et al : Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost, 17 : 1989-1994, 2019
残りの12件を表示する
- 6) Gando S et al : Role of disseminated intravascular coagu-lation in severe sepsis. Thromb Res, 178 : 182-188, 2019
- 7) Kudo D, et al : Permissive hypotension/hypotensive resus-citation and restricted/controlled resuscitation in patients with severe trauma. Journal of Intensive Care, 5, 2017
- 8) Saito S, et al : Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems. J Crit Care, 50 : 23-30, 2018
- 9) Hayakawa M, et al : Characteristics, treatments, and out-comes of severe sepsis of 3195 ICU-treated adult patients throughout Japan during 2011-2013. J Intensive Care, 4 : 44, 2016
- 10) Kushimoto S, et al : Clinical course and outcome of dissemi-nated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. comparison between sepsis and trauma. Thromb Haemost, 100 : 1099-1105, 2008
- 11) Levi M, et al : Sepsis, coagulation, and antithrombin: old lessons and new insights. Semin Thromb Hemost, 34 : 742-746, 2008
- 12) 日本集中治療医学会・日本救急医学会合同 日本版敗血症診療ガイドライン2020特別委員会・編 : 日本版敗血症診療ガイドライン2020. 日本集中治療医学会雑誌, 28(Suppl.) : S1-S411, 2021
- 13) Warren BL, et al : Caring for the critically ill patient. high-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA, 286 : 1869-1878, 2001
- 14) Kienast J, et al : Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost, 4 : 90-97, 2006
- 15) Abeyama K, et al : The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel anti-inflammatory mechanism. J Clin Invest, 115 : 1267-1274, 2005
- 16) Vincent JL, et al : Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA, 321 : 1993-2002, 2019
- 17) Iba T, et al : Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET. Acute Med Surg, 6 : 3-4, 2019
